- TRADE NAMES: Navane (Pfizer); Orbinamon
- INDICATIONS: Psychotic disorders
- CLASS: Antipsychotic
- HALF-LIFE: >24 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to view the rest of this drug profile.
Page last updated 03/13/2024